Our Stories

“The courage it takes to share your story might be the very thing someone else needs to open their heart to hope.” — Unknown

Dr. Paolo Angelini Contributes to the American College of Cardiology’s CathSAP

Texas Heart Institute cardiologist Paolo Angelini, MD, contributes to the American College of Cardiology’s CathSAP board-exam prep resource

Last year, the American College of Cardiology (ACC) requested that Texas Heart Institute cardiologist Dr. Paolo Angelini contribute his expertise to a module on coronary artery anomalies for the third edition of their online Cardiac Catheterization & Interventional Cardiology Self-Assessment Program (CathSAP) Board-exam preparation resource. The new content went live on Friday, January 14.

While CathSAP was created as a resource for physicians preparing to take the Interventional Cardiology Board exam, CathSAP can also be used to earn CME credit and MOC points for licensing and certification requirements. The ACC offers several such self-assessment and board-prep programs, including CathSAP, ACCSAP, EchoSAP, EP SAP, HF SAP, and ECG Drill & Practice.

Dr. Angelini was invited to contribute to the module because of his globally recognized expertise in the area of coronary artery anomalies (CAAs). His many contributions to the field include devising a classification system for CAAs that categorizes them as anomalies of origin and course, of coronary artery anatomy, and of coronary termination. Dr. Angelini also wrote a comprehensive textbook and atlas about CAAs. “This invitation is a well-deserved recognition of Dr. Angelini’s international reputation and expertise in this space,“ stated Dr. Joseph A. Rogers, Texas Heart Institute President, and CEO.

By Stephen Palmer, PhD, ELS


Texas Heart Institute (THI), founded by world-renowned cardiovascular surgeon Dr. Denton A. Cooley in 1962, is a nonprofit organization dedicated to delivering the future of cardiovascular health through exceptional patient care, discovery, and a commitment to learning. Participating in research programs in cardiology, cardiovascular surgery, stem cell and gene therapy, and regenerative medicine, THI’s scientists and physicians are spearheading some of the most innovative research in the medical field. Through its translational basic and clinical research programs, Texas Heart Institute is learning more every day about the underlying causes of heart disease and the ways to better treat and even prevent it. With initiatives ranging from postdoctoral and continued medical education to public outreach and scientific publications, THI is dedicated to spreading awareness and sharing updates on ways to prevent, treat and defeat cardiovascular disease. With over 12 million visitors coming to its website from around the world every year, www.texasheart.org is just one of the ways THI is helping to educate people on the importance of heart health. For more information, please visit https://www.texasheart.org@Texas_Heart